Clincosm LogoSign in Get a demo

Lymphoma, Non-Hodgkin

Showing 101 - 125 of 259
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

FLT-PET/CT vs FDG-PET/CT for Therapy Monitoring of Diffuse Large

Completed
  • Lymphoma
  • +2 more
  • FLT-PET/CT
  • +2 more
  • Los Angeles, California
  • +3 more
May 6, 2021

Acute Myeloid Leukemia, Chronic Lymphocytic Leukemia, Chronic Myeloid Leukemia Trial in Lebanon (drug, radiation, procedure)

Recruiting
  • Acute Myeloid Leukemia
  • +8 more
  • Lebanon, New Hampshire
    Dartmouth Hitchcock Medical Center, Norris Cotton Cancer Center
Apr 29, 2021

Lymphoma, Non-Hodgkin, Lymphoma Trial in Davis, San Diego, San Francisco (Carfilzomib, Bendamustine, Rituximab)

Completed
  • Lymphoma, Non-Hodgkin
  • Lymphoma
  • Davis, California
  • +2 more
Apr 21, 2021

Lymphoma, Small Lymphocytic, Lymphoma, Lymphoma, Non-Hodgkin Trial in United States (duvelisib, PI3K inhibitor)

Terminated
  • Lymphoma, Small Lymphocytic
  • +4 more
  • Little Rock, Arkansas
  • +10 more
Mar 15, 2021

Long-Term Survivors of Hodgkin's and Non-Hodgkin's Lymphoma

Completed
  • Hodgkin Disease
  • Lymphoma, Non-Hodgkin
  • Survey
  • Rochester, New York
    University of Rochester Medical Center
Mar 4, 2021

Symbenda Post-Marketing Surveillance (PMS)

Completed
  • Lymphoma, Non-Hodgkin
  • +2 more
    • Busan, Korea, Republic of
    • +8 more
    Jan 25, 2021

    Lymphoma, Non-Hodgkin, Diffuse Large B Cell Lymphoma, Follicular Lymphoma Trial in China (CD19-targeted Chimeric Antigen

    Recruiting
    • Lymphoma, Non-Hodgkin
    • +2 more
    • CD19-targeted Chimeric Antigen Receptor (CAR) T Cells
    • Beijing, Beijing, China
    • +9 more
    Jan 17, 2021

    MabThera Subcutaneous Safety in Non-Hodgkin's Lymphoma or

    Completed
    • Lymphoma, Non-Hodgkin
    • Leukemia, Lymphocytic, Chronic, B-Cell
    • Bucheon-si,, Korea, Republic of
    • +24 more
    Jan 7, 2021

    Lymphoma, Non-Hodgkin, HIV Trial in San Antonio (Mitoguazone)

    Completed
    • Lymphoma, Non-Hodgkin
    • HIV Infections
    • San Antonio, Texas
      ILEX Oncology Inc
    Dec 16, 2020

    Lymphoma, Non-Hodgkin, Hodgkin Disease, Multiple Myeloma Trial in United States (TXA127, Placebo)

    Terminated
    • Lymphoma, Non-Hodgkin
    • +2 more
    • Duarte, California
    • +9 more
    Dec 7, 2020

    Study of Lymphoma in Asia

    Completed
    • Lymphoma, Follicular
    • +5 more
      • Hexi District, China
      • +3 more
      Nov 24, 2020

      Lymphoma, Non-Hodgkin Trial in Sweden, United Kingdom (BAY1862864)

      Completed
      • Lymphoma, Non-Hodgkin
      • Lund, Sweden
      • +3 more
      Nov 23, 2020

      Lymphoma, Non-Hodgkin Trial in ChongQing (anti-CD19 FasT CAR-T cells)

      Not yet recruiting
      • Lymphoma, Non-Hodgkin
      • anti-CD19 FasT CAR-T cells
      • ChongQing, Chongqing, China
        Department of Hematology, Xinqiao Hospital
      Nov 19, 2020

      Lymphoma, Lymphoma, Non-Hodgkin, Lymphoma, B-Cell Trial in United States (OT-82 Dose Escalation, OT-82 Dose Expansion)

      Recruiting
      • Lymphoma
      • +6 more
      • OT-82 Dose Escalation
      • OT-82 Dose Expansion
      • Birmingham, Alabama
      • +7 more
      Oct 22, 2020

      Disease, Hodgkin, Lymphoma, Large-Cell, Anaplastic, Lymphoma, Non-Hodgkin Trial in Worldwide (brentuximab vedotin)

      No longer available
      • Disease, Hodgkin
      • +3 more
      • brentuximab vedotin
      • Stanford, California
      • +30 more
      Sep 17, 2020

      Lymphoma, Non-Hodgkin Trial in Worldwide (ABP 798, Rituximab)

      Completed
      Has Results
      • Lymphoma, Non-Hodgkin
      • ABP 798
      • Rituximab
      • Encinitas, California
      • +97 more
      Aug 7, 2020

      Lymphoma, Non-Hodgkin Trial in France, Germany, Korea, Republic of (BI 836826)

      Completed
      Has Results
      • Lymphoma, Non-Hodgkin
      • BI 836826
      • Marseille Cedex 09, France
      • +11 more
      Aug 10, 2020

      MDS (Myelodysplastic Syndrome), Myeloproliferative Disorder, Lymphoma, Non-Hodgkin Trial run by the NHLBI (Graft Manipulation

      Completed
      Has Results
      • MDS (Myelodysplastic Syndrome)
      • +4 more
      • Graft Manipulation (CD34+ Selection)
      • Bethesda, Maryland
        National Institutes of Health Clinical Center, 9000 Rockville Pi
      Jul 20, 2020

      Lymphoma, Non-Hodgkin Trial in Worldwide (Venetoclax, Cyclophosphamide, Obinutuzumab)

      Completed
      Has Results
      • Lymphoma, Non-Hodgkin
      • Fullerton, California
      • +51 more
      May 26, 2020

      Burkitt Lymphoma in East Africa Children or Minors (EMBLEM)

      Completed
      • Lymphoma, Non-Hodgkin
      • +2 more
        • Mwanza, Tanzania
        • +5 more
        May 21, 2020

        Bone Marrow Transplant Failure, Lymphoma, Non-Hodgkin, Lymphoma, T-Cell, Peripheral Trial in Canada, United States (Nilotinib)

        Completed
        • Bone Marrow Transplant Failure
        • +2 more
        • Stanford, California
        • +4 more
        Apr 13, 2020

        Lymphoma, Non-Hodgkin, Lymphoma, Follicular, Lymphoma, Large B-Cell, Diffuse Trial in Worldwide (PF-05082566, rituximab)

        Completed
        Has Results
        • Lymphoma, Non-Hodgkin
        • +6 more
        • Duarte, California
        • +41 more
        Mar 4, 2020

        Lymphoma, Non-Hodgkin Trial in Worldwide (pixantrone, cyclophosphamide, vincristine, rituximab, prednisone, Vinorelbine,

        Completed
        Has Results
        • Lymphoma, Non-Hodgkin
        • pixantrone, cyclophosphamide, vincristine, rituximab, prednisone
        • Vinorelbine, Oxalplatin, Ifosfasmide, Etoposide, Mitoxatrone, Gemcitabine or Rituximab
        • Fountain Valley, California
        • +98 more
        Jan 27, 2020

        Lymphoma, Non-Hodgkin, Granulocyte Colony-Stimulating Factor, Cost-Benefit Analysis Trial in Shanghai (PEG-rhG-CSF, rhG-CSF)

        Unknown status
        • Lymphoma, Non-Hodgkin
        • +2 more
        • Shanghai, Shanghai, China
          Ruijin hospital
        Sep 5, 2019

        Chronic Lymphocytic Leukemia, Lymphoma, Non-Hodgkin Trial in United States (Idelalisib)

        Terminated
        Has Results
        • Chronic Lymphocytic Leukemia
        • Lymphoma, Non-Hodgkin
        • Huntsville, Alabama
        • +17 more
        Aug 22, 2019